Announced details
Measurement of blood NAD+ levels before and after the intake of supplements and other products in clinics, aging care and related fields, and ongoing health management
Joint rollout. HMT will provide contracted testing services, and Rhelixa will provide the service to clinics.
Head office: 5F KDX Ginza East Building, 3-7-2 Irifune, Chuo-ku, Tokyo; President and Representative Director: Nakaki Ryu (仲木 竜); business activities: contract-based omics analysis and consulting services, and research and development and service provision related to anti-aging
Affiliated clinics nationwide
The impact on the Company’s financial results is expected to be minor
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | NAD+ Test for clinics (private-pay medical care) |
| Counterparty | 株式会社Rhelixa |
| Counterparty overview | Head office: 5F KDX Ginza East Building, 3-7-2 Irifune, Chuo-ku, Tokyo; President and Representative Director: Nakaki Ryu (仲木 竜); business activities: contract-based omics analysis and consulting services, and research and development and service provision related to anti-aging |
| Relationship with the Company | Joint rollout. HMT will provide contracted testing services, and Rhelixa will provide the service to clinics. |
| Contract Date | 7 August 2026 (agreement) |
| Launch date | 1 December 2026 (scheduled; applications to open) |
| Applicable area | Measurement of blood NAD+ levels before and after the intake of supplements and other products in clinics, aging care and related fields, and ongoing health management |
| Location | Affiliated clinics nationwide |
| Impact on Business Performance | The impact on the Company’s financial results is expected to be minor |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The service is ready for launch, and the two companies agreed on the launch date.